Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health & Wellness Today New York.
Press releases published on August 15, 2025
Cardiac Registry Support Doubles its Network and Expands into Bariatric Surgery Registry Support Following Acquisition
Leading cardiac registry firm acquires Lynne Thompson Consulting LLC dba Quality Health Data to enhance offerings, extend expertise to MBSAQIP and obesity care BROOKLYN, NY, UNITED STATES, August 15, 2025 /EINPresswire.com/ -- Cardiac Registry Support …
The Brookbush Institute Publishes a NEW Glossary Term: 'Levels of Evidence'
The Brookbush Institute continues to enhance education with new courses, a modern glossary, an AI Tutor, and a client program generator. NEW YORK, NY, UNITED STATES, August 15, 2025 /EINPresswire.com/ -- - Excerpt from Glossary Term: Levels of Evidence …
Lifebit Launches AI-Enhanced Health Data Intelligence Platform to Power Faster, Smarter Discovery
The only end-to-end health data intelligence platform that guarantees real-world results — now supercharged with AI. NEW YORK, NY, UNITED STATES, August 15, 2025 /EINPresswire.com/ -- Lifebit today announced the launch of its next-generation, end-to-end …
Fibroid Fighters: 'Your Health In Full Bloom' NY Event Celebrates Medical Advances for Comprehensive Health and Wellness
Event brings together nearly 500 attendees, health experts, and advocates, creating a supportive community for education, empowerment, entertainment and fun. NEW YORK, NY, UNITED STATES, August 15, 2025 /EINPresswire.com/ -- The Fibroid Fighters …
rYojbaba Co., Ltd. Announces Closing of $5 Million Initial Public Offering of Japanese Common Shares
FUKUOKA, Japan, Aug. 15, 2025 (GLOBE NEWSWIRE) -- rYojbaba Co., Ltd. (Nasdaq: RYOJ) (“rYojbaba” or the “Company”), a Japanese labor consulting and health services company, today announced the closing of its initial public offering of 1,250,000 Japanese …
BioSig Technologies, Inc. & Streamex Announce Closing of $15 Million Public Offering
Los Angeles, CA, Aug. 15, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (“BioSig” or the “Company”), which recently merged with Streamex Exchange Corporation (“Streamex”) (NASDAQ: BSGM), a gold tokenization infrastructure company, today announced the …
Allarity Therapeutics Provides Second Quarter 2025 Update, Highlighting Clinical Progress, IP Expansion, and New Partnerships
- Successfully initiated enrollment in advanced Phase 2 ovarian cancer trial - Expanded global IP protection by securing Australian patent acceptance for the stenoparib DRP® companion diagnostic - Secured new service contract with EU biotech for …
Jabez Biosciences, Inc. Opens Second Clinical Site in Phase 1 Oncology Clinical Study of JBZ-001
CRANBERRY TOWNSHIP, Pa., Aug. 15, 2025 (GLOBE NEWSWIRE) -- Jabez Biosciences, Inc., a clinical-stage biopharmaceutical company dedicated to ushering in the future of cancer therapy with their seamless, scalable and synergistic approach, today announced …
InnovAge Florida PACE – Tampa and Tampa General Hospital Form Joint Venture to Elevate PACE Services in Tampa
TAMPA, Fla., Aug. 15, 2025 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge”) (Nasdaq: INNV), a leader in senior care through the Program of All-inclusive Care for the Elderly (“PACE”), is proud to announce a new joint venture of its Tampa, Florida …
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BOSTON, Aug. 15, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective on August 12, 2025, the company issued inducement awards …
Breeze Holdings Acquisition Corp. Shareholders Approve Business Combination with YD Biopharma Limited
Transaction Expected to Close in the Coming Days Combined Company to be Named YD Bio Limited and Expected to Trade on Nasdaq Under Ticker Symbol “YDES” IRVING, Texas, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Breeze Holdings Acquisition Corp. (“Breeze”) (OTCQX: …
Tonix Pharmaceuticals Announces FDA Approval of Tonmya™ (cyclobenzaprine HCl sublingual tablets) for the Treatment of Fibromyalgia
Tonmya is the first FDA-approved therapy for the treatment of fibromyalgia in over 15 years Fibromyalgia is a chronic pain condition that affects more than 10 million adults in the U.S. who are mostly women Two Pivotal Phase 3 studies demonstrated Tonmya …
Dr. Gbolahan Okubadejo Now Offering Comprehensive Wellness For NYC Patients
NY Top Docs has reviewed and approved Gbolahan Okubadejo, MD, FAAOS of The Institute for Comprehensive Spine Care based on merit for 2025. BROOKLYN, NY, UNITED STATES, August 15, 2025 /EINPresswire.com/ -- NY Top Docs has reviewed and approved Gbolahan …
Bioxytran Unveils Revolutionary Precision Diagnostics on Tissue Oxygenation
Game changer for stroke, Alzheimer’s, and beyond Shifting from peripheral to tissue-specific oxygenation monitoring BOSTON, MASSACHUSETTS, Aug. 15, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a pioneering clinical stage …
Recor Medical Responds to the American Heart Association (AHA) and American College of Cardiology’s (ACC) Updated Guidelines on Renal Denervation for the Treatment of Hypertension
Palo Alto, CA, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Recor Medical, Inc. (“Recor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”), appreciate the American Heart Association (AHA) and American College of Cardiology (ACC) for …
La Croix-Rouge met sur pied un fonds de secours en réponse aux feux de forêt à Terre-Neuve
OTTAWA, Ontario, 15 août 2025 (GLOBE NEWSWIRE) -- La Croix-Rouge canadienne lance un appel aux dons au profit du Fonds de secours : Feux de forêt de 2025 à Terre-Neuve-et-Labrador afin de venir en aide aux personnes et aux communautés éprouvées par les …
HeartSciences Announces Conference Participation and Investor Webinar
Southlake, TX, Aug. 15, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (“AI”)-powered medical technology company transforming ECGs/EKGs to enable earlier detection of heart …
AIM ImmunoTech Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Continued progress across pipeline programs with focus on pancreatic cancer Mid-year report of Ampligen® (rintatolimod) in combination with AstraZeneca’s Imfinzi® (durvalumab) for the treatment of pancreatic cancer demonstrates promising signs of both no …